In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.
Academic rigour, journalistic flair
Articles on Drugs
Displaying 241 - 260 of 455 articles
GPs have been advised to limit prescriptions for certain medical conditions. It could save the NHS a fortune.
New findings show what the public really thinks about how we prioritise treatments at the end of people’s lives.
Sleeping tablets such as Ambien can have serious side effects.
Millions of dollars are lost each year by Australian’s caught in romance scams. But one Australian grandmother now faces paying a much higher price: she’s been sentenced to death.
You should be aware of the amount of genetic information you might disclose in a research study – and what the benefits and risks will be.
Most recreational users get their drugs from ‘social suppliers’. Law enforcement should concentrate on organised crime instead.
Medical marijuana? Recreational marijuana? Both or neither? Here’s a quick guide to the topsy-turvy landscape for marijuana regulation in the US.
More young people are using Xanax – but overdose, addiction and side effects present serious risks.
How can we increase safety and reduce the likelihood of sexual violence in chemsex settings? Addressing wider issues surrounding sexual consent might be a start.
Cocaine is the second most commonly used illicit substance in Australia, after marijuana.
Phenibut is a central nervous system depressant, and is currently being investigated for its possible role in seven overdoses at a Queensland school.
Recent deaths within the pornography industry in the US have reignited debates on labour conditions and mental health.
By undermining the ACA, Republicans may be taking away one of the health care system’s best tools for improving the lives of those with addiction.
LSD is far safer than alcohol or tobacco, so why don’t drug laws reflect it?
Health Canada is proposing to allow some prescription drugs into the country with only ‘cursory clinical review.’ Here’s why we should be worried.
Half of all patients diagnosed with cancer in the UK still die of the disease.
When after-school clubs aren’t properly monitored, they can become risky spaces.
Scientists are beginning to understand why certain drugs and musical genres are natural partners.
While young people are drinking less alcohol, older Australians are binge drinking more often – what’s going on?
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Senior Lecturer of Addiction, Edith Cowan University
-
Professor in Substance Use, Liverpool John Moores University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Vice Chancellor’s Senior Research Fellow, Social Equity Research Centre and Digital Ethnography Research Centre, RMIT University
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
University of Sydney
-
Lecturer, RMIT University
-
Senior Lecturer in Chemistry, University of Birmingham
-
PhD Candidate, Royal Holloway University of London
-
Senior Lecturer in Criminology, Deakin University
-
Professor & Specialist in Drug Policy, UNSW Sydney
